Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer

Published:2017-04 Issue: Volume:88 Page:374-383
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Yan Jieke,Wang Yuzhen,Jia Yuxiu,Liu Shuangde,Tian Chuan,Pan Wengu,Liu Xiaoli,Wang Hongwei

Funder

Seed Fund of the 2nd Hospital of Shandong University

Project of medical and health technology development program in Shandong province

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference43 articles.

1. Global cancer statistics;Jemal;CA. Cancer J. Clin.,2011

2. Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001–2007;Li;Prostate Cancer,2012

3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study;Berthold;J. Clin. Oncol.,2008

4. Update in systemic therapy of prostate cancer: improvement in quality and duration of life;Vaishampayan;Expert Rev. Anticancer Ther.,2008

5. Antiandrogens inhibit ABCB1 efflux and ATPase activity and reverse docetaxel resistance in advanced prostate cancer;Zhu;Clin. Cancer Res.,2015

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomedicines in diagnosis and treatment of prostate cancers: an updated review;Frontiers in Bioengineering and Biotechnology;2024-08-21

2. PLGA nanomedical consignation: A novel approach for the management of prostate cancer;International Journal of Pharmaceutics;2024-03

3. Nanotherapeutics for prostate cancer treatment: A comprehensive review;Biomaterials;2024-03

4. Targeting the prostate tumor microenvironment by plant-derived natural products;Cellular Signalling;2024-03

5. Multifunctional nanocarrier-mediated codelivery for targeting and treatment of prostate cancer;Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer Therapy;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3